Lori Hazlehurst, PhD., works in her lab in the Erma Byrd Biomedical Research Facility.
The Osborn Program brings together faculty from several departments, campuses, and disciplines who share interest in better understanding hematological malignancies, such as leukemia, as well as bone marrow transplantation. Work overseen by program members includes both clinical trials for patients seen at the Mary Babb Randolph Cancer Center (MBRCC), as well as laboratory based investigations.
Through collaboration between clinical and basic science colleagues we focus on projects that are designed to improve patient outcome through understanding the disease process and factors that impact on patient recovery follow bone marrow transplantation. The program is led by Lori Hazlehurst, PhD and a search for a medical co-leader is under way.
The philosophy of co-leadership is common across many of our MBRCC thematic areas to bring together basic science and clinical expertise to support the best science and patient care possible. A variety of trainees, including students and fellows, are involved in the Osborn Program investigations in an effort to prepare the next generation of clinicians and scientists to continue this effort. As a working team, the Osborn Program members remain committed to, and excited about, our potential to improve the outcome of patients with cancer.